BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.
Chang
Chung-Che Jeff
CC
Methodist Hospital Department of Pathology, Houston, Tex. 77030, USA. jeffchang@tmh.tmc.edu
D015415:Biomarkers / Q000378:metabolism; D001854:Bone Marrow Cells / Q000473:pathology; D049109:Cell Proliferation; D016313:Genes, abl; D006801:Humans; D053614:Janus Kinase 2; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D051562:Proto-Oncogene Proteins c-bcr / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
D015415:Biomarkers; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr